Chicago Equity Partners LLC acquired a new stake in shares of West Pharmaceutical Services, Inc. (NYSE:WST) in the second quarter, according to its most recent disclosure with the SEC. The firm acquired 7,770 shares of the medical instruments supplier’s stock, valued at approximately $734,000.
Other institutional investors and hedge funds also recently made changes to their positions in the company. Harfst & Associates Inc. purchased a new stake in West Pharmaceutical Services during the 1st quarter valued at approximately $186,000. Tyers Asset Management LLC grew its holdings in West Pharmaceutical Services by 17.6% during the 1st quarter. Tyers Asset Management LLC now owns 2,464 shares of the medical instruments supplier’s stock valued at $201,000 after buying an additional 368 shares in the last quarter. Cambridge Investment Research Advisors Inc. grew its holdings in West Pharmaceutical Services by 1.6% during the 1st quarter. Cambridge Investment Research Advisors Inc. now owns 2,569 shares of the medical instruments supplier’s stock valued at $210,000 after buying an additional 40 shares in the last quarter. CIBC Asset Management Inc purchased a new stake in West Pharmaceutical Services during the 2nd quarter valued at approximately $223,000. Finally, Koch Industries Inc. purchased a new stake in West Pharmaceutical Services during the 1st quarter valued at approximately $225,000. 91.25% of the stock is owned by institutional investors and hedge funds.
West Pharmaceutical Services, Inc. (NYSE:WST) opened at 91.43 on Monday. The company has a 50 day moving average of $87.56 and a 200-day moving average of $88.98. West Pharmaceutical Services, Inc. has a 12-month low of $70.17 and a 12-month high of $99.91. The stock has a market capitalization of $6.77 billion, a price-to-earnings ratio of 39.24 and a beta of 1.13.
West Pharmaceutical Services (NYSE:WST) last posted its quarterly earnings data on Thursday, July 27th. The medical instruments supplier reported $0.66 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $0.65 by $0.01. West Pharmaceutical Services had a return on equity of 14.02% and a net margin of 11.42%. The firm had revenue of $397.60 million during the quarter, compared to the consensus estimate of $406 million. During the same period in the prior year, the company earned $0.59 EPS. The firm’s revenue was up 2.5% compared to the same quarter last year. On average, equities research analysts forecast that West Pharmaceutical Services, Inc. will post $2.68 earnings per share for the current year.
The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, November 1st. Investors of record on Wednesday, October 18th will be paid a $0.14 dividend. This is an increase from West Pharmaceutical Services’s previous quarterly dividend of $0.13. This represents a $0.56 annualized dividend and a yield of 0.61%. The ex-dividend date is Tuesday, October 17th. West Pharmaceutical Services’s dividend payout ratio is currently 22.22%.
A number of equities research analysts have issued reports on the stock. Jefferies Group LLC reaffirmed a “hold” rating and set a $90.00 price objective on shares of West Pharmaceutical Services in a report on Thursday, June 8th. Zacks Investment Research raised shares of West Pharmaceutical Services from a “hold” rating to a “strong-buy” rating and set a $114.00 price objective for the company in a report on Friday, June 9th. Finally, BidaskClub lowered shares of West Pharmaceutical Services from a “strong-buy” rating to a “buy” rating in a report on Tuesday, June 13th. Two equities research analysts have rated the stock with a sell rating, one has given a hold rating and two have issued a buy rating to the stock. The stock has an average rating of “Hold” and a consensus price target of $90.18.
COPYRIGHT VIOLATION WARNING: “Chicago Equity Partners LLC Invests $734,000 in West Pharmaceutical Services, Inc. (WST) Stock” was first posted by Markets Daily and is the property of of Markets Daily. If you are accessing this story on another publication, it was illegally copied and reposted in violation of US and international trademark & copyright law. The legal version of this story can be read at https://www.themarketsdaily.com/2017/09/11/chicago-equity-partners-llc-invests-734000-in-west-pharmaceutical-services-inc-wst-stock.html.
West Pharmaceutical Services Company Profile
West Pharmaceutical Services, Inc is a manufacturer of packaging components and delivery systems for injectable drugs and healthcare products. The Company’s products include vial containment solutions, prefillable systems, self-injection platforms, cartridge systems and components, reconstitution and transfer systems, intradermal delivery solutions, specialty components, and contract manufacturing and analytical services.
Want to see what other hedge funds are holding WST? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for West Pharmaceutical Services, Inc. (NYSE:WST).
Receive News & Ratings for West Pharmaceutical Services Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for West Pharmaceutical Services Inc. and related companies with MarketBeat.com's FREE daily email newsletter.